Free online access available October 24 – October 31 PRINCETON, N.J, Oct. 29, 2025 /PRNewswire/ -- Learning Ally, a national…
Affordable, clinician-reviewed assessments help SBCC reach accommodation decisions sooner and keep students on track during critical academic periods. GRAND RAPIDS,…
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in…
Data Show Statistically Significant Improvements in Pain, Function and Tendon Structure in Appropriately Dosed PatientsGLASGOW, Scotland, Oct. 28, 2025 (GLOBE…
Approvals received from World Health Organization and United States Adopted Names Council establishing “xelafaslatide” as nonproprietary name for ONL1204 Ophthalmic…
Remedy Robotics selected as Mission Thrombectomy's exclusive robotics partner to broaden access to life-saving stroke treatment in the U.S. and…
KYV-101 resulted in a profound reduction in disease-associated autoantibodies and impact on disease activity in patients with difficult-to-treat rheumatoid arthritis…
Late-breaking positive Phase III data from ianalumab NEPTUNUS-1 and NEPTUNUS-2 trials in Sjögren’s disease to be presented Biomarker data informing…
HABRI and Mental Health America Partner to Offer Practical Information for Current and Prospective Pet Owners on the Mental Health…
The completely new in-the-ear hearing aid style is the world's first solution where users don't need to compromise between in-the-ear…